Alys Pharmaceuticals
PrivateLast Round
Seed
Feb 12, 2024
Total Funding Raised
$100M
Company Overview
Alys Pharmaceuticals is a biotechnology company that develops a pipeline of programs and platforms targeting multiple dermatological indications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alys Pharmaceuticals Comparables
Compare Alys Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dermaliq Therapeutics, Inc. | 81% | |
| DermBiont | 77% | |
| Ahammune Biosciences | 71% | |
Alys Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 12, 2024 |
Alys Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Medicxi | Seed |
Alys Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Alys Pharmaceuticals's valuation, stock price, and market status.